Therapeutic Use:

Indications for ALDACTONE:

Treatment of NYHA class III–IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure, when used in addition to standard therapy.

Adult:

Serum potassium ≤5.0mEq/L and eGFR >50mL/min: initially 25mg daily; may increase to 50mg daily if tolerant, or decrease to 25mg every other day if hyperkalemia develops. eGFR 30–50mL/min: consider initiating at 25mg every other day.

ClinicalAdvisor.com is for nurse practitioners and physician assistants, offering the latest information on diagnosing, treating, managing, and preventing medical conditions typically seen in the office-based primary-care setting.

Find all of the news and departments you love from the print issue archived for easy online access, along with special Web-only content.